The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.

Chip giant Nvidia ( NVDA) was more than 11% lower in the first hour of US trading. Industry peer ASML ( ASML) lost 8%, while Arm ( ARM ), Broadcom ( AVGO ), and Micron Technology ( MU) also got ...

Scientists at a university in the UK are in the midst of creating a breakthrough vaccine that could stop cancer in its tracks ...

Listen to this article Pharmaceutical company Haleon will invest $54.2 million to upgrade its research and development facility in Richmond and launch an internship program in partnership with state ...

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

This Fool considers how two low-risk and well-established FTSE shares could offer stability and growth during a period of market volatility.

Scientists at Oxford University, which pioneered Covid-19 vaccines, turn attention to ‘detecting the undetectable’ and ...

The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...

Oxford University is hoping to create a vaccine to stop the disease 20 years before it develops, as part of a joint project ...

A new partnership between the University of Oxford and GSK aims to develop vaccines against cancer before develop ...

A new cancer vaccine that ‘stops disease before you get it’ is being created by pharmaceutical giant GSK and the University ...